Study directory

Bipolarity studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
1909studies shown
Showing 193-204 of 1,909
Drug study icon
CompletedNCT01058668

Safety and Efficacy of Cariprazine for Bipolarity type I

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States, Croatia, Romania, ...
Sponsor
Forest Laboratories
Condition
Bipolarity
Drug study icon
CompletedNCT00665366

Aripiprazole Administered With Lithium or Valproate Over 12 Weeks for manic episodes in bipolarity type I

This study is completed in France, in Austria, in Czechia, .... It is testing Aripiprazole Administered With Lithium or Valproate Over 12 Weeks for manic episodes in bipolarity type I.

Multiple locations, including Salzburg
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugOver 18 Years
Countries
France, Austria, Czechia, ...
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Bipolarity
Other study type icon
CompletedNCT01455961

Clinical Practice Treatment for Bipolarity

This study is completed. It is testing clinical Practice Treatment for Bipolarity.

Location not clearly listed
Why is this study shown?

This study is directly about Bipolarity.

BipolarityObservationalA study where researchers collect information without assigning a treatment.
Countries
Sponsor
AstraZeneca
Condition
Bipolarity
Behavioral study icon
CompletedNCT01799291

Cognitive De-Biasing and the Assessment of Pediatric Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In Chapel Hill
Why is this study shown?

This study is directly about Bipolarity.

BipolarityBehavioral
Countries
United States
Sponsor
University of North Carolina, Chapel Hill
Condition
Bipolarity
Device study icon
CompletedNCT05272046

Monopolar and Bipolar Current RFA Knife in POEM

This study is looking at care and outcomes for people with Esophageal Motility Disorders. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.

Multiple locations, including Houston
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDeviceA study involving a tool, app, wearable, test, or medical device.Over 18 Years
Countries
United States, India, Spain
Sponsor
Baylor College of Medicine
Condition
Bipolarity
Drug study icon
CompletedNCT00761761

Sensoril(Ashwaganhda)for Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In Pittsburgh
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Pittsburgh
Condition
Bipolarity
Behavioral study icon
CompletedNCT04622150

Effectiveness RCT of Customized Adherence Enhancement

This study is looking at whether a digital support tool can help people with bipolarity. Participants receive a study treatment and complete follow-up visits and assessments.

Multiple locations, including Cleveland
Why is this study shown?

This study is directly about Bipolarity.

BipolarityBehavioralFrom 18 Years to 89 Years
Countries
United States
Sponsor
Case Western Reserve University
Condition
Bipolarity
Behavioral study icon
CompletedNCT05741268

Effect of Dialectical Behavior in people with Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In Alexandria
Why is this study shown?

This study is directly about Bipolarity.

BipolarityBehavioralFrom 50 Years to 55 Years
Countries
Egypt
Sponsor
Alexandria University
Condition
Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.